In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
from NYT > World > Americas https://ift.tt/p9SBg6K
Ozempic Is About to Go Generic in India, China and Canada
0
March 18, 2026
